`
`
`
`UNITED STATES PATENT AND TRADEMARK OFFICE
`
`____________
`
`BEFORE THE PATENT TRIAL AND APPEAL BOARD
`
`____________
`
`COALITION FOR AFFORDABLE DRUGS II LLC.
`Petitioner
`v.
`
`NPS PHARMACEUTICALS, INC.
`Patent Owner
`
`____________
`
`Case IPR2015-01093
`
`Patent 7,056,886
`
`____________
`
`NPS PHARMACEUTICALS, INC.’s
`
`INTERROGATORIES TO PETITIONER
`
`
`
`
`
`1
`
`NPS EX. 2002
`CFAD v. NPS
`IPR2015-01093
`
`
`
`Patent Owner NPS Pharmaceuticals, Inc. (“NPS”) requests Petitioner to
`
`respond and serve written response to the following interrogatories pursuant to
`
`Federal Rule of Civil Procedure 26(a) and Office Patent Trial Practice Guide.
`
`I. INSTRUCTIONS AND DEFINITIONS
`
`
`
`NPS incorporates-by-reference the Instructions and Definitions of NPS’s
`
`Request for Production to Petitioner (Ex. 2001).
`
`
`
`II. INTERROGATORIES
`
`INTERROGATORY No. 1
`
`Please identify by name and address each Named and Unnamed Funder.
`
`INTERROGATORY No. 2
`
`Please identify by name and address each investor, owner, partner, limited
`
`partner, general partner, member, manager, shareholder, beneficiary, beneficial
`
`owner, control person, investment manager, trustee, investment advisor,
`
`investment advisee, officer, director, and feeder fund of each Named and Unnamed
`
`Funder and the duties, responsibilities, ownership interest, investment amount,
`
`income, rights, and equity of each in or from such Named or Unnamed Funder.
`
`
`
`
`
`2
`
`